Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths
- PMID: 29209720
- PMCID: PMC5770276
- DOI: 10.1001/jama.2017.17627
Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths
Erratum in
-
Adjusted Data for 2013 Birth Cohort in a Table.JAMA. 2018 Sep 25;320(12):1288. doi: 10.1001/jama.2018.13235. JAMA. 2018. PMID: 30264095 No abstract available.
Abstract
Importance: In 2011, critical congenital heart disease was added to the US Recommended Uniform Screening Panel for newborns, but whether state implementation of screening policies has been associated with infant death rates is unknown.
Objective: To assess whether there was an association between implementation of state newborn screening policies for critical congenital heart disease and infant death rates.
Design, setting, and participants: Observational study with group-level analyses. A difference-in-differences analysis was conducted using the National Center for Health Statistics' period linked birth/infant death data set files for 2007-2013 for 26 546 503 US births through June 30, 2013, aggregated by month and state of birth.
Exposures: State policies were classified as mandatory or nonmandatory (including voluntary policies and mandates that were not yet implemented). As of June 1, 2013, 8 states had implemented mandatory screening policies, 5 states had voluntary screening policies, and 9 states had adopted but not yet implemented mandates.
Main outcomes and measures: Numbers of early infant deaths (between 24 hours and 6 months of age) coded for critical congenital heart disease or other/unspecified congenital cardiac causes for each state-month birth cohort.
Results: Between 2007 and 2013, there were 2734 deaths due to critical congenital heart disease and 3967 deaths due to other/unspecified causes. Critical congenital heart disease death rates in states with mandatory screening policies were 8.0 (95% CI, 5.4-10.6) per 100 000 births (n = 37) in 2007 and 6.4 (95% CI, 2.9-9.9) per 100 000 births (n = 13) in 2013 (for births by the end of July); for other/unspecified cardiac causes, death rates were 11.7 (95% CI, 8.6-14.8) per 100 000 births in 2007 (n = 54) and 10.3 (95% CI, 5.9-14.8) per 100 000 births (n = 21) in 2013. Early infant deaths from critical congenital heart disease through December 31, 2013, decreased by 33.4% (95% CI, 10.6%-50.3%), with an absolute decline of 3.9 (95% CI, 3.6-4.1) deaths per 100 000 births after states implemented mandatory screening compared with prior periods and states without screening policies. Early infant deaths from other/unspecified cardiac causes declined by 21.4% (95% CI, 6.9%-33.7%), with an absolute decline of 3.5 (95% CI, 3.2-3.8) deaths per 100 000 births. No significant decrease was associated with nonmandatory screening policies.
Conclusions and relevance: Statewide implementation of mandatory policies for newborn screening for critical congenital heart disease was associated with a significant decrease in infant cardiac deaths between 2007 and 2013 compared with states without these policies.
Conflict of interest statement
Figures
Comment in
-
The Success of State Newborn Screening Policies for Critical Congenital Heart Disease.JAMA. 2017 Dec 5;318(21):2087-2088. doi: 10.1001/jama.2017.17626. JAMA. 2017. PMID: 29209703 No abstract available.
Similar articles
-
Actions in Support of Newborn Screening for Critical Congenital Heart Disease - United States, 2011-2018.MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):107-111. doi: 10.15585/mmwr.mm6805a3. MMWR Morb Mortal Wkly Rep. 2019. PMID: 30730872 Free PMC article.
-
Causes of death and infant mortality rates among full-term births in the United States between 2010 and 2012: An observational study.PLoS Med. 2018 Mar 20;15(3):e1002531. doi: 10.1371/journal.pmed.1002531. eCollection 2018 Mar. PLoS Med. 2018. PMID: 29558463 Free PMC article.
-
State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):625-30. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26086632 Free PMC article.
-
Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.Semin Perinatol. 2015 Apr;39(3):230-7. doi: 10.1053/j.semperi.2015.03.007. Semin Perinatol. 2015. PMID: 25979782 Free PMC article. Review.
-
Screening for Critical Congenital Heart Disease.Clin Perinatol. 2016 Mar;43(1):73-80. doi: 10.1016/j.clp.2015.11.005. Clin Perinatol. 2016. PMID: 26876122 Review.
Cited by
-
[Neonatal screening for critical congenital heart diseases in Peru: an urgent call].Arch Peru Cardiol Cir Cardiovasc. 2024 Sep 29;5(3):157-166. doi: 10.47487/apcyccv.v5i3.366. eCollection 2024 Jul-Sep. Arch Peru Cardiol Cir Cardiovasc. 2024. PMID: 39411017 Free PMC article. Review. Spanish.
-
The Performance of Critical Congenital Heart Disease Screening in Rural Versus Urban Locations in the Northwest United States.J Pediatr Clin Pract. 2024 Jul 4;14:200120. doi: 10.1016/j.jpedcp.2024.200120. eCollection 2024 Dec. J Pediatr Clin Pract. 2024. PMID: 39314999 Free PMC article.
-
Survival of Children With Critical Congenital Heart Defects in the National Birth Defects Prevention Study.Birth Defects Res. 2024 Sep;116(9):e2394. doi: 10.1002/bdr2.2394. Birth Defects Res. 2024. PMID: 39258453 Free PMC article.
-
Addressing Disparities in Pediatric Congenital Heart Disease: A Call for Equitable Health Care.J Am Heart Assoc. 2024 Jul 2;13(13):e032415. doi: 10.1161/JAHA.123.032415. Epub 2024 Jun 27. J Am Heart Assoc. 2024. PMID: 38934870 Free PMC article. Review.
-
Machine Learning-Based Critical Congenital Heart Disease Screening Using Dual-Site Pulse Oximetry Measurements.J Am Heart Assoc. 2024 Jun 18;13(12):e033786. doi: 10.1161/JAHA.123.033786. Epub 2024 Jun 15. J Am Heart Assoc. 2024. PMID: 38879455 Free PMC article.
References
-
- Kemper AR, Mahle WT, Martin GR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011;128(5):e1259–e1267. - PubMed
-
- Mahle WT, Newburger JW, Matherne GP, et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research; American Academy of Pediatrics Section on Cardiology and Cardiac Surgery, and Committee on Fetus and Newborn. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation. 2009;120(5):447–458. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
